Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-19-017640

Director bought 8,888,888 shares at $2.25 ($19,999,998)

From the SEC's structured data for this filing

Trades in this filing

AFEYAN NOUBAR · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-18 Purchase : show line 1 in the form +4,444,444 $2.25 $9,999,999 4,444,444 I
2019-06-18 Purchase : show line 2 in the form +4,444,444 $2.25 $9,999,999 4,444,444 I
Open-market purchases · 8,888,888 sh · avg $2.25 · $19,999,998
Loading xslF345X03/doc4.xml…